Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System - Summary - MDSpire
To characterize dispensing trends and costs for the new respiratory-use medications incorporated into Colombia’s Resolution 2292 of 2021.
Approach:
Study Design: A longitudinal observational study assessed trends in the utilization and costs of respiratory-management medications among outpatients recorded in a population drug-dispensary database.
Population: The study included approximately 9.2 million individuals affiliated with the Colombian Health System, representing 30% of the contributory regime and 6% of the state-subsidized regime.
Data Collection: Medication dispensing data were obtained from Audifarma SA, covering the period from January 1, 2021, to June 30, 2023.
Key Findings:
Utilization and associated costs of respiratory medications rose significantly following the 2022 Benefit Plan update.
Gaps involving recommended first-line therapies were filled, indicating changes in prescribing and dispensing practices.
Interpretation:
The inclusion of new respiratory medications in the 2022 Benefit Plan has led to increased medication consumption and costs.
Limitations:
The study only assessed outpatient data and may not reflect inpatient medication utilization.
The analysis was limited to medications listed under the 2022 Benefit Plan.
Conclusion:
The update to the Benefit Plan has positively impacted the availability of respiratory therapies in Colombia.
by Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Andrés Gaviria-Mendoza, Juan Pablo Albanes-Beltrán, Giovanny Mesa-Escobar, Ana Camila Delgado-Araujo, María Camila Oyuela-Gutiérrez, Santiago Rubio-Londoño, Jorge Enrique Machado-Alba
A cross-sectional metagenomic study found greater oral microbiome richness among adults with chronic rhinosinusitis, particularly nonallergic chronic rhinosinusitis, while associations with asthma, airway inflammation, and most lung-function measures were inconsistent.
